NJ federal judge rules Teva inhaler patents are 'improperly listed' in Orange Book
Five of Teva’s inhaler patents are “improperly listed” in the FDA’s Orange Book, a federal judge ruled Monday, in a win for Amneal Pharmaceuticals’ efforts …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.